返回 Agendas
SAS Institute Inc., JMP Division Innovation Theater: Benefit and Risk Signal Detection in Clinical Trials
Session Chair(s)
JMP Statistical Discovery
United States
Integrated assessment of both efficacy and safety data in clinical trials has become an increasingly common analytic goal in clinical trials. There is an intrinsic balance between the desired outcomes of a treatment versus the risks that may be incurred to achieve such outcomes. We describe how analytic capabilities tightly tied with visualization in JMP Clinical software can elucidate understanding for both safety and efficacy endpoints during the analysis process.
注册方法
Registration override should work.